Results 251 to 260 of about 170,196 (315)
Phenotypic Clues in Infantile‐Onset Parkinsonism‐Dystonia‐2: A Treatable Neurotransmitter Disorder
Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan +10 more
wiley +1 more source
Severe Lower Limb and Abdominal Edema Associated with Subcutaneous Apomorphine Infusion
Movement Disorders Clinical Practice, EarlyView.
Guillaume Costentin, David Maltête
wiley +1 more source
Corrigendum to "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". [PDF]
Ther Adv Psychopharmacoleuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Dermatology, 2004
Whereas several drugs to treat most other chronic conditions have been developed over the last 30 years, progress in pharmacologic therapy for obesity has been slow. The record of drug treatment for obesity partly explains this phenomenon and is of concern. Several compounds have been withdrawn when severe side effects have been discovered. The lack of
Yvonne, Linné, Stephan, Rössner
openaire +4 more sources
Whereas several drugs to treat most other chronic conditions have been developed over the last 30 years, progress in pharmacologic therapy for obesity has been slow. The record of drug treatment for obesity partly explains this phenomenon and is of concern. Several compounds have been withdrawn when severe side effects have been discovered. The lack of
Yvonne, Linné, Stephan, Rössner
openaire +4 more sources
Pharmacotherapy of fibromyalgia
American Journal of Health-System Pharmacy, 2011Published evidence on the pathophysiology, diagnosis, and treatment of fibromyalgia is reviewed, with an emphasis on recent clinical trials of various pharmacologic agents.Fibromyalgia affects an estimated 2% of the general U.S. population, and its incidence is sevenfold higher among women.
Laura M, Traynor +2 more
openaire +4 more sources
Pharmacotherapy of Fibromyalgia
Rheumatic Disease Clinics of North America, 2009Advances have occurred in the pharmacotherapy of fibromyalgia (FM) and the methodology of clinical trial design in FM in parallel with improved understanding of the underlying pathophysiologic mechanisms. Several medications have been approved for the management of FM based on their clinically meaningful and durable effect on pain in monotherapy trials
Philip J, Mease, Ernest H, Choy
openaire +2 more sources
Nature Reviews Drug Discovery, 2002
Addiction to drugs, such as heroin, cocaine and alcohol, exacts great human and financial costs on society, but the development of pharmacotherapies for addiction has been largely neglected by the pharmaceutical industry. With advances in our understanding of the underlying biology of addictions now opening the door for the development of novel ...
Mary Jeanne, Kreek +2 more
openaire +2 more sources
Addiction to drugs, such as heroin, cocaine and alcohol, exacts great human and financial costs on society, but the development of pharmacotherapies for addiction has been largely neglected by the pharmaceutical industry. With advances in our understanding of the underlying biology of addictions now opening the door for the development of novel ...
Mary Jeanne, Kreek +2 more
openaire +2 more sources